The researchers — led by David C. Mohr, PhD, of the Center for Behavioral Intervention Technologies at Chicago-based Northwestern University Feinberg School of Medicine — developed the app suite, which is designed for frequent, but short, interactions. For the study, they identified 99 participants to use the app suite in an effort to evaluate its efficacy at reducing depression and anxiety symptoms.
The participants, who received eight weeks of coaching on the use of IntelliCare, had access to 14 IntelliCare apps. The majority of participants, 95 percent, downloaded at least five of the apps. On average, participants used the apps 195.4 times over the course of eight weeks; the average length of use was 1.1 minutes. Overall, participants showed reductions in depression and anxiety symptoms, based on patient questionnaires.
The researchers concluded, “This study supports the IntelliCare framework of providing a suite of skills-focused apps that can be used frequently and briefly to reduce symptoms of depression and anxiety.”
More articles on health IT:
4 states join national prescription data sharing network
FDA, IBM Watson Health to study use of blockchain in health data exchange
Cal INDEX, Inland Empire HIE to form California’s largest HIE
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
